Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Dual effects of JAK vs TNF inhibitors on osteoporosis, fractures and mortality in rheumatoid arthritis
 
  • Details
Options

Dual effects of JAK vs TNF inhibitors on osteoporosis, fractures and mortality in rheumatoid arthritis

Other Title
a real-world cohort study
Journal
Frontiers in Immunology
Date Issued
2026-01-01
Author(s)
JAMES CHENG-CHUNG WEI  
DOI
10.3389/fimmu.2026.1745048
URI
https://www.scopus.com/pages/publications/105034955244
https://scholars.csmu.edu.tw/handle/123456789/28829
Abstract
Purpose – This real-world study compared the effects of JAK inhibitors (JAKi) versus TNF inhibitors (TNFi) on bone health and survival in rheumatoid arthritis (RA) patients. Methods – We conducted a retrospective cohort study using the collaborative electronic health records (EHR) database network (2016-2024). After 1:1 propensity score matching, 16, 572 JAKi and 16, 572 TNFi users were included, with follow-up for up to 5 years. Primary outcomes were a composite of “any fracture or osteoporosis, ” individual fracture and osteoporosis events, and all-cause mortality. Results – In the propensity score–matched cohort, JAKi use was associated with a lower risk of the composite outcome (HR = 0.930) and osteoporosis (HR = 0.906) compared with TNFi. However, a reduction in fracture risk was not clearly observed. JAKi use was also associated with higher all-cause mortality (HR = 1.582). Subgroup estimates suggested potential heterogeneity, but these findings were exploratory. Conclusion – In this large EHR-based cohort, JAKi initiation was associated with lower rates of osteoporosis-related outcomes but higher all-cause mortality compared with TNFi. Given the observational design, potential residual confounding, and limited follow-up for many patients, these findings should be interpreted as associations and warrant confirmation in other datasets and prospective studies. Rationale – To compare real-world associations of JAKi vs TNFi with bone outcomes and all-cause mortality in RA. Main result – In a propensity score–matched cohort, JAKi use was associated with lower osteoporosis-related outcomes but higher all-cause mortality compared with TNFi. Significance – These observational findings suggest a potential trade-off and highlight the need for individualized risk–benefit discussions and confirmation in other datasets/prospective studies.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback